Mounjaro Cuts Heart Attack Risk by 33% | Leeds News

New real-world data reveals Mounjaro slashes heart attack risk by 33% in type two diabetes patients with heart disease—compared to sitagliptin—based on a massive study of nearly 53,000 people. After one year, Mounjaro prevented major cardiovascular events, hospitalizations for infections, and deaths, offering doctors and patients clearer, powerful evidence to guide treatment decisions. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/d38a40041a4f1259